BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19197380)

  • 1. Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation.
    Kartal Durmazlar SP; Akgul A; Eskioglu F
    Mediators Inflamm; 2008; 2008():407972. PubMed ID: 19197380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nitric oxide synthase activity, nitric oxide, and homocysteine levels in patients with active Behcet's disease.
    Taysi S; Sari RA; Dursun H; Yilmaz A; Keles M; Cayir K; Akyuz M; Uyanik A; Guvenc A
    Clin Rheumatol; 2008 Dec; 27(12):1529-34. PubMed ID: 18636307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of resistin in Behçet's disease: a Turkish experiment.
    Pehlivan Y; Onat AM; Okumuş S; Kisacik B; Comez G; Comez A; Goktepe F; Ceylan NO
    Mod Rheumatol; 2012 Aug; 22(4):571-5. PubMed ID: 22038316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M; Frigui M; Chaabouni Kh; Turki M; Neifer M; Lahiyani A; Messaouad M; Bahloul Z; Ayedi F; Jamoussi K
    Gene; 2013 Sep; 527(1):306-10. PubMed ID: 23827456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine: an activity marker in Behçet's disease?
    Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
    J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of inflammatory markers and echocardiographic parameters in Behçet's disease.
    Çalık AN; Özcan KS; Mesci B; Çınar T; Çanga Y; Güngör B; Kavala M; Oğuz A; Bolca O; Kozan Ö
    Acta Cardiol; 2020 Apr; 75(2):130-137. PubMed ID: 30689956
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma homocysteine level and uveitis in Behçet's disease.
    Okka M; Oztürk M; Kockar MC; Bavbek N; Rasier Y; Gunduz K
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):931-4. PubMed ID: 12455183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A; Cure MC; Cure E; Arslan S; Unal M; Sakiz D; Ozucan M; Toker A; Turkmen K; Kucuk A
    Acta Medica (Hradec Kralove); 2018; 61(3):86-92. PubMed ID: 30543512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
    Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
    Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
    Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.
    Jung YS; Kim SW; Yoon JY; Lee JH; Jeon SM; Hong SP; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2011 Oct; 17(10):2130-7. PubMed ID: 21910175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of IgG antibodies against alpha-enolase are increased in patients with Behçet's disease and are associated with the severity of oral ulcer, erythrocyte sedimentation rates, and C-reactive protein.
    Kang SE; Lee SJ; Lee JY; Yoo HJ; Park JK; Lee EY; Lee EB; Song YW
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):67-74. PubMed ID: 28770703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of serum interleukin-20 levels in patients with Behçet's disease.
    Enecik ME; Mavi B; Yücel Ç; Keskin G; Yıldız M
    Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
    Balkarli A; Kucuk A; Babur H; Erbasan F
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum angiopoietin-1 level is increased in patients with Behçet's disease.
    Choe JY; Park SH; Kim SK
    Joint Bone Spine; 2010 Jul; 77(4):340-4. PubMed ID: 20471887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation and homocysteine levels in Behçet's disease.
    Mungan AG; Can M; Açikgöz S; Eştürk E; Altinyazar C
    Clin Chem Lab Med; 2006; 44(9):1115-8. PubMed ID: 16958606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine is a determinant of tissue necrosis factor-alpha in hypertensive patients.
    Bogdanski P; Pupek-Musialik D; Dytfeld J; Lacinski M; Jablecka A; Jakubowski H
    Biomed Pharmacother; 2008; 62(6):360-5. PubMed ID: 18093792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.